{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:55:18Z","timestamp":1784757318745,"version":"3.55.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T00:00:00Z","timestamp":1464220800000},"content-version":"vor","delay-in-days":391,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jacc.2015.03.567","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T11:21:49Z","timestamp":1432034509000},"page":"2225-2238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Bleeding Avoidance Strategies During Percutaneous Coronary Interventions"],"prefix":"10.1016","volume":"65","author":[{"given":"Mandeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.03.567_bib1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/CIRCOUTCOMES.110.957290","article-title":"Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding","volume":"3","author":"Amin","year":"2010","journal-title":"Circ Cardiovas Qual Outcomes"},{"key":"10.1016\/j.jacc.2015.03.567_bib2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jcin.2013.08.002","article-title":"Systematic\u00a0use of transradial PCI in patients with ST-segment elevation myocardial infarction: a call\u00a0to \u201carms.\u201d","volume":"6","author":"Eleid","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib3","doi-asserted-by":"crossref","first-page":"e000021","DOI":"10.1136\/openhrt-2013-000021","article-title":"Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis","volume":"1","author":"Kwok","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2015.03.567_bib4","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.jacc.2014.05.075","article-title":"Baseline bleeding risk and arterial access site practice in relation to procedural outcomes after percutaneous coronary intervention","volume":"64","author":"Mamas","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jama.2013.1556","article-title":"Association between bleeding events and in-hospital mortality after percutaneous coronary intervention","volume":"309","author":"Chhatriwalla","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.03.567_bib6","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.111.060871","article-title":"Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention","volume":"125","author":"Ndrepepa","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.03.567_bib7","unstructured":"Centers for Medicare &Medicaid Services. Details for title: Medicare Acute Care Episode (ACE) demonstration. 2009. Available at: http:\/\/www.cms.gov\/Medicare\/Demonstration-Projects\/DemoProjectsEvalRpts\/Medicare-Demonstrations-Items\/CMS1204388.html. Accessed April 1,\u00a02015."},{"key":"10.1016\/j.jacc.2015.03.567_bib8","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1001\/jama.2010.708","article-title":"Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention","volume":"303","author":"Marso","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.03.567_bib9","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.567_bib10","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.03.567_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jcin.2013.04.016","article-title":"An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry","volume":"6","author":"Rao","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/0003-4819-115-4-256","article-title":"Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial","volume":"115","author":"Bovill","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2015.03.567_bib13","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/01.CIR.0000162477.70955.5F","article-title":"Association of hemoglobin levels with clinical outcomes in acute coronary syndromes","volume":"111","author":"Sabatine","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.03.567_bib14","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jacc.2011.12.045","article-title":"Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry","volume":"59","author":"Subherwal","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jcin.2010.10.011","article-title":"Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention","volume":"4","author":"Verheugt","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jcin.2013.03.010","article-title":"Prognostic significance of bleeding location and severity among patients with acute coronary syndromes","volume":"6","author":"Vavalle","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jcin.2007.12.006","article-title":"Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005","volume":"1","author":"Doyle","year":"2008","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/CIRCINTERVENTIONS.108.846741","article-title":"Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry","volume":"2","author":"Mehta","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/CIRCINTERVENTIONS.109.860494","article-title":"Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry","volume":"2","author":"Ahmed","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jcin.2008.03.013","article-title":"Trends in vascular complications after diagnostic\u00a0cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007","volume":"1","author":"Applegate","year":"2008","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jacc.2010.05.008","article-title":"Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention","volume":"56","author":"Roe","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2011.02.039","article-title":"Bleeding avoidance strategies: consensus and controversy","volume":"58","author":"Dauerman","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib23","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.jacc.2013.02.017","article-title":"Pre-procedural estimate of individualized bleeding risk impacts physicians' utilization of bivalirudin during percutaneous coronary intervention","volume":"61","author":"Rao","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.mayocp.2014.03.004","article-title":"Risk scores for 30-day mortality after percutaneous coronary intervention: new insights into causes and risk of death","volume":"89","author":"Singh","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2015.03.567_bib25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0025-6196(11)61190-7","article-title":"Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores","volume":"82","author":"Singh","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2015.03.567_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0735-1097(02)01980-0","article-title":"Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention","volume":"40","author":"Singh","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jcin.2011.02.011","volume":"4","author":"Mehran","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib28","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.jacc.2013.02.030","article-title":"Patterns of use and comparative effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study from the National Cardiovascular Data Registry","volume":"61","author":"Daugherty","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0002-9149(03)00972-X","article-title":"Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions","volume":"92","author":"Kinnaird","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib30","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.amjcard.2007.06.026","article-title":"Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial","volume":"100","author":"Feit","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib31","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jacc.2007.10.040","article-title":"Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point","volume":"51","author":"Ndrepepa","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.amjcard.2009.08.668","article-title":"Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality","volume":"105","author":"Ndrepepa","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11239-010-0462-8","article-title":"Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction","volume":"30","author":"Amlani","year":"2010","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2015.03.567_bib34","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.jacc.2008.12.073","article-title":"Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice","volume":"53","author":"Doyle","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib35","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/j.0041-1132.2004.04128.x","article-title":"Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions","volume":"44","author":"Tsai","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.jacc.2015.03.567_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpa.2007.01.004","article-title":"The impact of storage on red cell function in blood transfusion","volume":"21","author":"Almac","year":"2007","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib37","doi-asserted-by":"crossref","first-page":"17058","DOI":"10.1073\/pnas.0707958104","article-title":"S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood","volume":"104","author":"Reynolds","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2015.03.567_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11239-006-5206-4","article-title":"Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions","volume":"21","author":"Twomley","year":"2006","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2015.03.567_bib39","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jama.2014.980","article-title":"Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention","volume":"311","author":"Sherwood","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.03.567_bib40","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.292.13.1555","article-title":"Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes","volume":"292","author":"Rao","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.03.567_bib41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty","volume":"330","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.567_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)85010-1","article-title":"Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.03.567_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0735-1097(00)00746-4","volume":"36","author":"Cho","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib44","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.03.567_bib45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0735-1097(02)02767-5","article-title":"Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial","volume":"41","author":"Tolleson","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib46","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib47","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.567_bib48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.03.567_bib49","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1053\/euhj.2000.2474","article-title":"The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease","volume":"21","author":"Mehta","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.03.567_bib50","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.567_bib51","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","article-title":"Intravenous platelet blockade with cangrelor during PCI","volume":"361","author":"Bhatt","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.567_bib52","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.567_bib53","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jama.292.6.696","article-title":"Long-term efficacy of bivalirudin and provisional glycoprotein IIb\/IIIa blockade vs heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial","volume":"292","author":"Lincoff","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.03.567_bib54","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.03.567_bib55","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.567_bib56","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJMoa0802944","article-title":"Bivalirudin versus unfractionated heparin during percutaneous coronary intervention","volume":"359","author":"Kastrati","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.567_bib57","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1311096","article-title":"Bivalirudin started during emergency transport for primary PCI","volume":"369","author":"Steg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.567_bib58","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(14)61216-2","article-title":"Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials","volume":"384","author":"Cavender","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.03.567_bib59","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","volume":"384","author":"Shahzad","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.03.567_bib60","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/hrt.2011.224709","volume":"97","author":"Koutouzis","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2015.03.567_bib61","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2015.2323","article-title":"Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The BRIGHT Randomized Clinical Trial","author":"Han","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.03.567_bib62","unstructured":"Valgimigli M. Bivalirudin infusion compared to unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: results from the Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Anti-thrombin Program. Paper presented at: ACC.15; March 15, 2015; San Diego, California."},{"key":"10.1016\/j.jacc.2015.03.567_bib63","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1161\/CIRCULATIONAHA.112.000536","article-title":"Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007\u20132012)","volume":"127","author":"Feldman","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.03.567_bib64","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1161\/CIRCULATIONAHA.111.032235","article-title":"Femoral arterial access and closure","volume":"124","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.03.567_bib65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ccd.20897","article-title":"Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal","volume":"69","author":"Cantor","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000362536","article-title":"Femoral micropuncture or routine introducer study (FEMORIS)","volume":"129","author":"Ambrose","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2015.03.567_bib67","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jcin.2010.04.015","article-title":"Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial)","volume":"3","author":"Seto","year":"2010","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib68","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jacc.2013.08.1651","article-title":"ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial","volume":"63","author":"Bernat","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib69","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2012.06.017","article-title":"Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study","volume":"60","author":"Romagnoli","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib70","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(11)60404-2","article-title":"Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial","volume":"377","author":"Jolly","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.03.567_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)60292-6","article-title":"Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial","author":"Valgimigli","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.03.567_bib72","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjcard.2012.03.051","article-title":"Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention","volume":"110","author":"Bertrand","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib73","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jcin.2014.04.007","article-title":"A\u00a0registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial","volume":"7","author":"Rao","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib74","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jacc.2013.10.052","article-title":"Procedural volume and outcomes with radial or femoral access for coronary angiography and intervention","volume":"63","author":"Jolly","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib75","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jacc.2014.03.002","article-title":"SCAI\/ACC\/AHA expert consensus Document: 2014 update on percutaneous coronary intervention without on-site surgical backup","volume":"63","author":"Dehmer","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib76","first-page":"535","article-title":"Switching from transfemoral to transradial access for PCI: a single-center learning curve over 5 years","volume":"26","author":"Bundhoo","year":"2014","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib77","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/CIRCULATIONAHA.113.006356","article-title":"The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry","volume":"129","author":"Hess","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.03.567_bib78","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.114.010061","article-title":"The pace of transradial procedural learning","volume":"129","author":"Abbott","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.03.567_bib79","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/CIRCINTERVENTIONS.111.965871","article-title":"Radial artery patency after transradial catheterization","volume":"5","author":"Kotowycz","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib80","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ccd.21639","article-title":"Prevention of radial artery occlusion-patent hemostasis evaluation trial (PROPHET study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization","volume":"72","author":"Pancholy","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib81","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ccd.21900","article-title":"Radial compression guided by mean artery pressure versus standard compression with a pneumatic device (RACOMAP)","volume":"73","author":"Cubero","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib82","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ccd.25209","article-title":"Best practices for transradial angiography and intervention: a consensus statement from the society for cardiovascular angiography and intervention's transradial working group","volume":"83","author":"Rao","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib83","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jacc.2013.12.043","article-title":"Transradial coronary catheterization and intervention across the whole spectrum of Allen test results","volume":"63","author":"Valgimigli","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib84","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.291.3.350","article-title":"for the Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis","volume":"291","author":"Koreny","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.03.567_bib85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4244\/EIJV7I2A38","article-title":"The Angio-Seal femoral closure device allows immediate ambulation after coronary angiography and percutaneous coronary intervention","volume":"7","author":"Hvelplund","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2015.03.567_bib86","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ccd.1143","article-title":"Suture closure of the femoral arteriotomy following invasive cardiac procedures: a detailed analysis of efficacy, complications, and the impact of early ambulation in 1,200 consecutive, unselected cases","volume":"53","author":"Fram","year":"2001","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib87","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ccd.25663","article-title":"Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial","volume":"85","author":"Sanborn","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib88","first-page":"562","article-title":"Closure device or manual compression in patients undergoing percutaneous coronary intervention: a randomized comparison","volume":"22","author":"Hermanides","year":"2010","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib89","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCINTERVENTIONS.109.896704","article-title":"Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial","volume":"3","author":"Sanborn","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib90","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-159-10-201311190-00004","article-title":"Comparative safety of vascular closure devices and manual closure among patients having percutaneous coronary intervention","volume":"159","author":"Gurm","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2015.03.567_bib91","first-page":"328","article-title":"Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies","volume":"24","author":"Tavris","year":"2012","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jacc.2015.03.567_bib92","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ahj.2009.12.027","article-title":"Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty","volume":"159","author":"Biancari","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2015.03.567_bib93","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2010.1633","article-title":"Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices","volume":"304","author":"Resnic","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.03.567_bib94","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcin.2011.09.017","article-title":"Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry","volume":"5","author":"Resnic","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib95","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1067\/mva.2001.115002","article-title":"Iatrogenic vascular injuries from percutaneous vascular suturing devices","volume":"33","author":"Nehler","year":"2001","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jacc.2015.03.567_bib96","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCINTERVENTIONS.109.877407","article-title":"Vascular closure device failure: frequency and implications: a propensity-matched analysis","volume":"2","author":"Bangalore","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib97","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jcin.2012.05.005","article-title":"Vascular closure device failure in contemporary practice","volume":"5","author":"Vidi","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2013.06.016","article-title":"Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry","volume":"7","author":"Tsai","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib99","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial","volume":"377","author":"Stone","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.03.567_bib100","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.4244\/EIJV8I11A192","volume":"8","author":"Hamon","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2015.03.567_bib101","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ahj.2008.08.023","article-title":"Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials","volume":"157","author":"Jolly","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2015.03.567_bib102","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcin.2013.10.016","article-title":"Usefulness of baseline activated clotting time-guided heparin administration in reducing bleeding events during transfemoral transcatheter aortic valve implantation","volume":"7","author":"Bernelli","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib103","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ccd.24913","article-title":"A\u00a0comparison of the femoral and radial crossover techniques for vascular access management in transcatheter aortic valve implantation: the Milan experience","volume":"83","author":"Curran","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.567_bib104","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jcin.2013.08.004","article-title":"A\u00a0randomized comparison of the transradial and transfemoral approaches for coronary artery bypass graft angiography and intervention: the RADIAL-CABG Trial (RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention)","volume":"6","author":"Michael","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.567_bib105","unstructured":"Ottawa Heart Institute Research Corporation.\u00a0Femoral Versus Radial Access for Primary PC\u00a0(SAFARI-STEMI). 2015. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01398254. Accessed April 2,\u00a02015."},{"key":"10.1016\/j.jacc.2015.03.567_bib106","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMe0906549","article-title":"Ticagrelor\u2014is there need for a new player in the antiplatelet-therapy field?","volume":"361","author":"Schomig","year":"2009","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715017830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715017830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T09:59:26Z","timestamp":1537610366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109715017830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":106,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0735109715017830"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.03.567","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding Avoidance Strategies During Percutaneous Coronary Interventions","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.03.567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}